{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:10:54Z","timestamp":1767708654991,"version":"3.48.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX24_1565"],"award-info":[{"award-number":["SJCX24_1565"]}]},{"name":"the Open Fund Project of Jiangsu Provincial Key Laboratory of Colleges and Universities","award":["XZSYSKF2022007"],"award-info":[{"award-number":["XZSYSKF2022007"]}]},{"name":"the Xuzhou Health Commission Special Fund Planning Project","award":["2019TD005"],"award-info":[{"award-number":["2019TD005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumour-derived exosomes are involved in various cancer processes, including invasion, metastasis, and tumour microenvironment (TME) remodelling. However, the function and mechanism of exosomes in ovarian cancer (OC) are still under investigation. The present study investigated the effects of tumour-derived exosomes on the carcinogenesis and progression of OC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>OC gene expression profiles were obtained from The Cancer Genome Atlas (TCGA) database and two independent Gene Expression Omnibus (GEO) datasets (GSE7463 and GSE12470). The exosome related genes were obtained by intersecting with OC related exosomes in the ExoCarta database, subsequently, the exosome genes of interst were identified through performing survival analysis in the GEPIA database.The expression of genes selected were validated in OC cell lines (SKOV3, OVCAR3 and A2780) and ascites of OC patients through western blot and PCR. And further knockdown and overexpression of this gene were performed in OC cells to detect their effects on cell proliferation, migration, and invasion. Subsequently, the potential biological functions and regulatory mechanisms were explored based on the Gene Set Enrichment Analysis (GSEA), and changes in relevant target proteins were validated through western blot. Furthermore, SKOV3-luc\u2009+\u2009cells were injected intraperitoneally into female BALB\/c nude mice to construct an in orthotopic xenograft mouse model, in order to evaluate the effect of differential genes on in vivo OC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on the results of bioinformatics analysis, TACSTD2 was selected for experimental validation. Cell function experiments verified that exosomal TACSTD2 promoted proliferation and metastasis by mediating glycolysis in OC. Animal experiments indicated that exosomal TACSTD2 promoted abdominal metastasis in OC. The in vitro and in vivo experimental results were consistent with the bioinformatics analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TACSTD2, which can be detected in ovarian cancer-derived exosomes, plays an important role in the invasion, migration and glycolysis in ovarian cancer. Furthermore, we have discovered that TACSTD2 may promote the progression of ovarian cancer by regulating glycolysis. Further research will enable its potentially prognostic marker and therapeutic target for ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-025-04041-6","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:50:58Z","timestamp":1764694258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal TACSTD2 promotes invasion, metastasis and glycolysis in ovarian cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Qisheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Adu-Amankwaah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"9","key":"4041_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/1471-0528.17446","volume":"130","author":"QR Chen","year":"2023","unstructured":"Chen QR, Shi JY, Ruan DH, Bian C. The diagnostic and therapeutic prospects of exosomes in ovarian cancer. Bjog-an Int J Obstet Gynecol. 2023;130(9):999\u20131006.","journal-title":"Bjog-an Int J Obstet Gynecol"},{"issue":"1","key":"4041_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca-a Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"Ca-a Cancer J Clin"},{"issue":"4","key":"4041_CR3","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer Statistics, 2018. Ca-a Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"Ca-a Cancer J Clin"},{"issue":"3","key":"4041_CR4","first-page":"183","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. Ca-a Cancer J Clin. 2011;61(3):183\u2013203.","journal-title":"Ca-a Cancer J Clin"},{"key":"4041_CR5","doi-asserted-by":"crossref","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. Bmj-British Med J 2020, 371.","DOI":"10.1136\/bmj.m3773"},{"issue":"6478","key":"4041_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):640\u2013.","journal-title":"Science"},{"key":"4041_CR7","doi-asserted-by":"crossref","unstructured":"Pegtel DM, Gould SJ. Exosomes. In: Annual Review of Biochemistry, Vol 88. Volume 88, edn. Edited by Kornberg RD; 2019: 487\u2013514.","DOI":"10.1146\/annurev-biochem-013118-111902"},{"issue":"2","key":"4041_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu DH. Exosomes in cancer development, metastasis, and immunity. Biochim Et Biophys Acta-Reviews Cancer. 2019;1871(2):455\u201368.","journal-title":"Biochim Et Biophys Acta-Reviews Cancer"},{"key":"4041_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejpb.2019.10.005","volume":"145","author":"SE Emam","year":"2019","unstructured":"Emam SE, Abu Lila AS, Elsadek NE, Ando H, Shimizu T, Okuhira K, Ishima Y, Mahdy MA, Ghazy FES, Ishida T. Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues. Eur J Pharm Biopharm. 2019;145:27\u201334.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"4041_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","volume":"335","author":"M Katakowski","year":"2013","unstructured":"Katakowski M, Buller B, Zheng XG, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013;335(1):201\u20134.","journal-title":"Cancer Lett"},{"key":"4041_CR11","doi-asserted-by":"crossref","unstructured":"Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. Delivery of functional Anti-miR-9 by mesenchymal stem Cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Therapy-Nucleic Acids 2013, 2.","DOI":"10.1038\/mtna.2013.60"},{"issue":"1","key":"4041_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2015.04.026","volume":"364","author":"I Hazan-Halevy","year":"2015","unstructured":"Hazan-Halevy I, Rosenblum D, Weinstein S, Bairey O, Raanani P, Peer D. Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer Lett. 2015;364(1):59\u201369.","journal-title":"Cancer Lett"},{"key":"4041_CR13","doi-asserted-by":"crossref","unstructured":"Pan ZW, Zhao RR, Li BY, Qi YH, Qiu W, Guo QD, Zhang SJ, Zhao SL, Xu H, Li M et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer 2022, 21(1).","DOI":"10.1186\/s12943-021-01485-6"},{"issue":"1","key":"4041_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1158\/1541-7786.MCR-16-0191","volume":"15","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Sawada K, Kinose Y, Yoshimura A, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Morishige K, Kurachi H, et al. Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells. Mol Cancer Res. 2017;15(1):78\u201392.","journal-title":"Mol Cancer Res"},{"key":"4041_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.omtn.2019.09.032","volume":"18","author":"X Guan","year":"2019","unstructured":"Guan X, Zong ZH, Liu Y, Chen S, Wang LL, Zhao Y. circPUM1 promotes tumorigenesis and progression of ovarian cancer by sponging miR-615-5p and miR-6753-5p. Mol Therapy-Nucleic Acids. 2019;18:882\u201392.","journal-title":"Mol Therapy-Nucleic Acids"},{"issue":"2","key":"4041_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/iep.12174","volume":"97","author":"N Xu","year":"2016","unstructured":"Xu N, Zhang Z, Zhu J, Xu L, Li Y, Duan L, Mao Y, Li H. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Int J Exp Pathol. 2016;97(2):150\u20138.","journal-title":"Int J Exp Pathol"},{"issue":"11","key":"4041_CR17","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.7150\/jca.95269","volume":"15","author":"X Han","year":"2024","unstructured":"Han X, Gao Y, Jiang M, Li Z, Guo J, Li Y, Yi J, Hou L, Cheng J, Feng L, et al. Single-cell and Spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. J Cancer. 2024;15(11):3427\u201340.","journal-title":"J Cancer"},{"key":"4041_CR18","doi-asserted-by":"crossref","unstructured":"Yokoi A, Ukai M, Yasui T, Inokuma Y, Hyeon-Deuk K, Matsuzaki J, Yoshida K, Kitagawa M, Chattrairat K, Iida M et al. Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires. Sci Adv 2023, 9(27).","DOI":"10.1126\/sciadv.ade6958"},{"issue":"43","key":"4041_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4041_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstr\u00e5le M, Laurila E, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"key":"4041_CR21","doi-asserted-by":"crossref","unstructured":"Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev 2021, 178.","DOI":"10.1016\/j.addr.2021.113961"},{"key":"4041_CR22","doi-asserted-by":"crossref","unstructured":"Payton C, Pang LY, Gray M, Argyle DJ. Exosomes derived from radioresistant breast cancer cells promote therapeutic resistance in Naive recipient cells. J Personalized Med 2021, 11(12).","DOI":"10.3390\/jpm11121310"},{"key":"4041_CR23","doi-asserted-by":"crossref","unstructured":"Hong P, Yang H, Wu Y, Li K, Tang Z. The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review. Stem Cell Res Ther 2019, 10(1).","DOI":"10.1186\/s13287-019-1358-y"},{"issue":"D1","key":"4041_CR24","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4041_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169(3):381\u2013405.","journal-title":"Cell"},{"key":"4041_CR26","doi-asserted-by":"crossref","unstructured":"Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J. IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways. J Experimental Clin Cancer Res 2018, 37.","DOI":"10.1186\/s13046-018-0980-3"},{"key":"4041_CR27","doi-asserted-by":"crossref","unstructured":"Wang L, Zhang B, Zheng W, Kang M, Chen Q, Qin W, Li C, Zhang Y, Shao Y, Wu Y. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K\/Akt\/FoxO1 pathway. Sci Rep 2017, 7.","DOI":"10.1038\/s41598-017-05541-4"},{"key":"4041_CR28","doi-asserted-by":"crossref","unstructured":"Wang W, Jiang X, Xia F, Chen X, Li G, Liu L, Xu Q, Zhu M, Chen C. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K\/AKT\/FOXO1 feedback loop in bladder cancervol 50, pg 453, (2023). Molecular Biology Reports 2023.","DOI":"10.1007\/s11033-022-07978-x"},{"issue":"2","key":"4041_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ygyno.2016.05.028","volume":"142","author":"L Hernandez","year":"2016","unstructured":"Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecol Oncol. 2016;142(2):332\u201340.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4041_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","volume":"138","author":"AK Mitra","year":"2015","unstructured":"Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, et al. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecol Oncol. 2015;138(2):372\u20137.","journal-title":"Gynecol Oncol"},{"key":"4041_CR31","doi-asserted-by":"crossref","unstructured":"Ran F, Zhang Y, Shi Y, Liu J, Li H, Ding L, Ye Q. miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis. Journal of Oncology 2021, 2021.","DOI":"10.1155\/2021\/5529770"},{"key":"4041_CR32","doi-asserted-by":"crossref","unstructured":"Yin Z-y, He S-m, Zhang X-y, Yu X-c, Sheng K-x, Fu T, Jiang Y-x, Xu L, Hu B-x, Zhang J-. b : Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid\/ER stress axis-induced Blockade of autophagy. Acta Pharmacol Sin 2025.","DOI":"10.1038\/s41401-024-01470-x"},{"issue":"7","key":"4041_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/onc.2016.253","volume":"36","author":"F Wendler","year":"2017","unstructured":"Wendler F, Favicchio R, Simon T, Alifrangis C, Stebbing J, Giamas G. Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention. Oncogene. 2017;36(7):877\u201384.","journal-title":"Oncogene"},{"issue":"5","key":"4041_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","volume":"21","author":"L Cheng","year":"2022","unstructured":"Cheng L, Hill AF. Therapeutically Harnessing extracellular vesicles. Nat Rev Drug Discovery. 2022;21(5):379\u201399.","journal-title":"Nat Rev Drug Discovery"},{"key":"4041_CR35","doi-asserted-by":"crossref","unstructured":"Cheng L, Wu S, Zhang K, Qing Ya, Xu T. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies. J Ovarian Res 2017, 10.","DOI":"10.1186\/s13048-017-0368-6"},{"key":"4041_CR36","doi-asserted-by":"crossref","unstructured":"Shimizu A, Sawada K, Kimura T. Pathophysiological role and potential therapeutic exploitation of exosomes in ovarian cancer. Cells 2020, 9(4).","DOI":"10.3390\/cells9040814"},{"key":"4041_CR37","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2147\/OTT.S162447","volume":"12","author":"S Zaman","year":"2019","unstructured":"Zaman S, Jadid H, Denson AC, Gray JE. Targeting Trop-2 in solid tumors: future prospects. Oncotargets Therapy. 2019;12:1781\u201390.","journal-title":"Oncotargets Therapy"},{"issue":"2","key":"4041_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/onc.2012.36","volume":"32","author":"M Trerotola","year":"2013","unstructured":"Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, Lattanzio R, de Lange R, Weidle UH, Piantelli M, et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene. 2013;32(2):222\u201333.","journal-title":"Oncogene"},{"issue":"11","key":"4041_CR39","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/hep4.1242","volume":"2","author":"STK Sin","year":"2018","unstructured":"Sin STK, Li Y, Liu M, Yuan Y-F, Ma S, Guan X-Y. \/i\u2009>\u2009Predicts poor prognosis of hepatocellular carcinoma patients. Hepatol Commun. 2018;2(11):1408\u201314.","journal-title":"Hepatol Commun"},{"key":"4041_CR40","doi-asserted-by":"crossref","unstructured":"Erber R, Spoerl S, Mamilos A, Krupar R, Hartmann A, Ruebner M, Taxis J, Wittenberg M, Reichert TE, Spanier G et al. Impact of spatially heterogeneous Trop-2 expression on prognosis in oral squamous cell carcinoma. Int J Mol Sci 2022, 23(1).","DOI":"10.3390\/ijms23010087"},{"issue":"1","key":"4041_CR41","first-page":"73","volume":"9","author":"M Shen","year":"2021","unstructured":"Shen M, Liu S, Stoyanova T. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target. Am J Clin Experimental Urol. 2021;9(1):73\u201387.","journal-title":"Am J Clin Experimental Urol"},{"issue":"9","key":"4041_CR42","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/IGC.0b013e318228f6da","volume":"21","author":"E Bignotti","year":"2011","unstructured":"Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, et al. Trop-2 overexpression in poorly differentiated endometrial endometrioid Carcinoma\u2009<\u2009i\u2009>\u2009Implications for immunotherapy with hRS. Int J Gynecol Cancer. 2011;21(9):1613\u201321.","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"4041_CR43","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1021\/pr3008732","volume":"11","author":"C-L Chen","year":"2012","unstructured":"Chen C-L, Lai Y-F, Tang P, Chien K-Y, Yu J-S, Tsai C-H, Chen H-W, Wu C-C, Chung T, Hsu C-W, et al. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res. 2012;11(12):5611\u201329.","journal-title":"J Proteome Res"},{"key":"4041_CR44","doi-asserted-by":"crossref","unstructured":"Kotrbova AV, Gomoryova K, Mikulova A, Plesingerova H, Sladecek S, Kravec M, Hrachovinova S, Potesil D, Dunsmore G, Bleriot C et al. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer. J Extracell Vesicles 2024, 13(3).","DOI":"10.1002\/jev2.12420"},{"key":"4041_CR45","doi-asserted-by":"crossref","unstructured":"Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer 2019, 18(1).","DOI":"10.1186\/s12943-019-1049-4"},{"key":"4041_CR46","doi-asserted-by":"crossref","unstructured":"He Q, Ye A, Ye W, Liao X, Qin G, Xu Y, Yin Y, Luo H, Yi M, Xian L et al. Cancer-secreted Exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis 2021, 12(6).","DOI":"10.1038\/s41419-021-03803-8"},{"issue":"2","key":"4041_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12272-019-01127-y","volume":"42","author":"M-K Shin","year":"2019","unstructured":"Shin M-K, Cheong J-H. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells. Arch Pharm Res. 2019;42(2):113\u201327.","journal-title":"Arch Pharm Res"},{"key":"4041_CR48","doi-asserted-by":"crossref","unstructured":"Ren X, Kang C, Garcia-Contreras L, Kim D. Understanding of ovarian cancer Cell-Derived exosome tropism for future therapeutic applications. Int J Mol Sci 2023, 24(9).","DOI":"10.3390\/ijms24098166"},{"key":"4041_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.01.004","volume":"67","author":"RJ Lobb","year":"2017","unstructured":"Lobb RJ, Lima LG, Moller A. Exosomes: key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol. 2017;67:3\u201310.","journal-title":"Semin Cell Dev Biol"},{"issue":"1\u20132","key":"4041_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-019-09794-5","volume":"38","author":"J Lu","year":"2019","unstructured":"Lu J. The Warburg metabolism fuels tumor metastasis. Cancer Metastasis Rev. 2019;38(1\u20132):157\u201364.","journal-title":"Cancer Metastasis Rev"},{"key":"4041_CR51","doi-asserted-by":"crossref","unstructured":"Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Therapy 2020, 5(1).","DOI":"10.1038\/s41392-020-00359-5"},{"issue":"2","key":"4041_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, O\u2019Connor STF, Li S, Chin AR, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17(2):183\u2013.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4041_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcb.2017.10.010","volume":"28","author":"K Rohlenova","year":"2018","unstructured":"Rohlenova K, Veys K, Miranda-Santos I, De Bock K, Carmeliet P. Endothelial cell metabolism in health and disease. Trends Cell Biol. 2018;28(3):224\u201336.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4041_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metabol. 2016;23(1):27\u201347.","journal-title":"Cell Metabol"},{"key":"4041_CR55","doi-asserted-by":"crossref","unstructured":"Jin G-Z, Zhang Y, Cong W-M, Wu X, Wang X, Wu S, Wang S, Zhou W, Yuan S, Gao H et al. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking. PLoS Biol 2018, 16(10).","DOI":"10.1371\/journal.pbio.2006483"},{"issue":"2","key":"4041_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"4041_CR57","doi-asserted-by":"crossref","unstructured":"Weh E, Lutrzykowska Z, Smith A, Hager H, Pawar M, Wubben TJ, Besirli CG. Hexokinase 2 is dispensable for photoreceptor development but is required for survival during aging and outer retinal stress. Cell Death Dis 2020, 11(6).","DOI":"10.1038\/s41419-020-2638-2"},{"issue":"1","key":"4041_CR58","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1038\/s41467-024-52915-0","volume":"15","author":"Y Loriot","year":"2024","unstructured":"Loriot Y, Kamal M, Syx L, Nicolle R, Dupain C, Menssouri N, Duquesne I, Lavaud P, Nicotra C, Ngocamus M, et al. The genomic and transcriptomic landscape of metastastic urothelial cancer. Nat Commun. 2024;15(1):8603.","journal-title":"Nat Commun"},{"issue":"6","key":"4041_CR59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1593\/neo.04379","volume":"6","author":"SS El Sheikh","year":"2004","unstructured":"El Sheikh SS, Domin J, Abel P, Stamp G. Lalani El N: phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia (New York NY). 2004;6(6):846\u201353.","journal-title":"Neoplasia (New York NY)"},{"issue":"48","key":"4041_CR60","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1038\/s41388-020-01487-6","volume":"39","author":"OJ Kwon","year":"2020","unstructured":"Kwon OJ, Zhang L, Jia D, Zhou Z, Li Z, Haffner M, Lee JK, True L, Morrissey C, Xin L. De Novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-Myc. Oncogene. 2020;39(48):7142\u201351.","journal-title":"Oncogene"},{"issue":"10","key":"4041_CR61","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1111\/jcmm.14579","volume":"23","author":"M Zheng","year":"2019","unstructured":"Zheng M, Cao M-x, Luo X-j, Li L, Wang K, Wang S-s, Wang H-f, Tang Y-j. Tang Y-l, Liang X-h: EZH2 promotes invasion and tumour Glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. J Cell Mol Med. 2019;23(10):6942\u201354.","journal-title":"J Cell Mol Med"},{"key":"4041_CR62","doi-asserted-by":"crossref","unstructured":"Catalano M, O\u2019Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles 2020, 9(1).","DOI":"10.1080\/20013078.2019.1703244"},{"key":"4041_CR63","doi-asserted-by":"crossref","unstructured":"Hekmatirad S, Moloudizargari M, Moghadamnia AA, Kazemi S, Mohammadnia-Afrouzi M, Baeeri M, Moradkhani F, Asghari MH. Inhibition of exosome release sensitizes U937 cells to pegylated liposomal doxorubicin. Front Immunol 2021, 12.","DOI":"10.3389\/fimmu.2021.692654"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04041-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:07:24Z","timestamp":1767708444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04041-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4041"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04041-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the principles expressed in the Declaration of Helsinki and was approved by Xuzhou Central Hospital\u2019s Ethics Committee (grant number: XZXY-LK-20230626-099) and the Animal Ethical and Welfare Committee of Xuzhou Medical University (grant number: 202302T010). The maximal tumor size permitted by our institutional ethics committee guidelines is 2\u00a0cm in diameter. We confirm that the maximal tumor size\/burden as outlined by our ethics committee was not exceeded at any point during the study. In all cases, animals were closely monitored, and any discomfort or significant tumor growth was addressed promptly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}